1,200
Participants
Start Date
November 17, 2016
Primary Completion Date
October 22, 2027
Study Completion Date
October 22, 2027
Pembrolizumab 200 mg
IV Q3W
Olaparib 400 mg
Eight 50-mg capsules PO BID
Docetaxel 75 mg/m^2
IV Q3W
Prednisone 5 mg
One 5-mg tablet PO BID
Enzalutamide 160 mg
Four 40-mg capsules, four 40-mg tablets, or two 80-mg tablets PO QD
Dexamethasone 8 mg
Premedication for Cohort B given PO at 12, 3, and 1 hours prior to docetaxel infusion Q3W
Olaparib 300 mg
Two 150-mg tablets PO BID
Abiraterone acetate 1000 mg
Two 500-mg or four 250-mg tablets PO QD
Lenvatinib
20 mg PO QD
Pembrolizumab/Vibostolimab coformulation
IV Q3W
Carboplatin
IV Q3W
Etoposide
IV on Days 1, 2 and 3 of each cycle
Belzutifan 120mg
PO QD
RECRUITING
Call for Information (Investigational Site 0008), Pittsburgh
RECRUITING
Call for Information (Investigational Site 2065), Charleston
RECRUITING
Call for Information (Investigational Site 0019), Myrtle Beach
RECRUITING
Call for Information (Investigational Site 2091), Cleveland
RECRUITING
Call for Information (Investigational Site 2041), Aurora
RECRUITING
Call for Information (Investigational Site 0005), Los Angeles
RECRUITING
Call for Information (Investigational Site 2027), Portland
RECRUITING
Call for Information (Investigational Site 2094), Portland
RECRUITING
Call for Information (Investigational Site 0016), Seattle
RECRUITING
MSD Australia, North Ryde
RECRUITING
MSD Denmark, Glostrup Municipality
RECRUITING
MSD France, Paris
RECRUITING
MSD Sharp & Dohme GmbH, München
RECRUITING
MSD Ireland (Human Health) Ltd., Dublin
RECRUITING
MSD Italia S.r.l., Rome
RECRUITING
MSD Comercializadora, S. de R.L. de C.V., Mexico City
RECRUITING
Merck Sharp & Dohme BV, Haarlem
RECRUITING
Merck Sharp & Dohme (New Zealand) Ltd.,, Auckland
RECRUITING
MSD Polska Sp. Z o.o., Warsaw
RECRUITING
Merck Sharp and Dohme de Espana S.A., Madrid
RECRUITING
MSD Sweden, Stockholm
RECRUITING
Merck Sharp & Dohme Ilaclari Ltd. Sti, Istanbul
RECRUITING
Merck Sharp & Dohme Ltd., London
RECRUITING
Merck Canada, Kirkland
Merck Sharp & Dohme LLC
INDUSTRY